Globally, the emergence of multidrug resistant strains of Mycobacterium tuberculosis is an increasing problem which adversely affects patient care and public health. In contrast to other bacteria, resistance of M. tuberculosis is exclusively associated with chromosomal mutation. Resistance of M. tuberculosis to anti-tuberculosis drugs is the result of a spontaneous genetic event and, worse, "a man-made amplification of the natural phenomenon" 6 . The global magnitude of drug resistance tuberculosis is not well described. A worldwide survey was performed by World Health Organization/ International Union against Tuberculosis and Lung Disease (WHO/IUATLD) global surveillance project between 1994 to 1997 revealed drug resistances varied from 2.3 % to 42.4 %. Rates of drug resistance to isoniazid range from 2.3% to 39.0%,
Introduction:
Tuberculosis is a disease of great antiquity and caused more suffering and death than any other bacterial infections 1 . It causes one billion deaths in the last 200 years 2 . Deaths from tuberculosis comprise 25% of all avoidable deaths in the developing countries. 95% of tuberculosis cases and 98% of tuberculosis deaths are in developing countries; 75% of these cases are in the economically productive age group (15-50 yrs). 3 Tuberculosis is one of the major health problems in Bangladesh. Recent estimate suggest that 2.3% of the population of Bangladesh get infected with tuberculosis every year, and about 300000 people progress to develop disease Results A total of 101 sputum smear positive pulmonary tuberculosis patients were studied. Among 101 cases 73 (72.28 %) were male and remaining 28 (27.72%) were female. The ratio of male and female was 2.61:1. Majority, 76 (75.25%) of them were in the age group of 15 to 44 years with peak incidence in 25-34 years of age 35 (34.65 %).
Of the 101 cases majority of them 79 (78.22%) were in lowincome group and only 22 (21.78%) from middle-income group. No patient was from upper-income group. Majority, 62 (61.39%) of the patients came from urban area . Of these 101 smear positive cases, culture for Mycobacteria were positive in 96 (95.05%) cases, contamination in 3 (2.97%) and no growth of Mycobacteria in 2 (1.98%) cases (Table-I) . Three consecutive morning sputum samples from each patient were collected in properly labeled screw cap disposable plastic bottles after oral gurgling with normal water. All samples were carried to Department of Microbiology, Armed Forces institute of Pathology (AFIP), Dhaka, where further processing was done. Sputum samples were processed and stained by Ziehl-Neelsen (Z-N) method and examined for Acid-Fast Bacilli (AFB). One sputum sample from each smear positive patient was processed, inoculated in MB/BacT automated culture bottle contain Middlebrook 7H9 broth and incubated in automated culture system (MB/BacT automated culture system, Organon Teknika, USA) at 37°C for six weeks according to the manufacturer's instructions.
The preliminary identification of mycobacterium isolate depends on their growth in MB/BacT bottle and detected and displayed on monitor and growth rate. Specific identification is accomplished by the performance of Z-N stain and battery of biochemical tests.
Sensitivity tests against Isoniazid (INH), Rifampicin (RMP), Streptomycin (SM), Ethambutol (EMB), and Pyrazinamide (PZA) were done by proportion method on LowensteinJensen (L-J) media.
All inoculated L-J drug and control media were incubated at 37 0 C for 3 weeks. The media were examined at 48 hours then weekly. The reading for drug susceptibility were taken at 3 weeks as after that drug deterioration may allow growth of susceptible organisms. The reading of growth on control and drug containing media were recorded according to Kent and Kubica 11 . Drug resistance was expressed in Proportion Method, where a strain is considered to be drug resistance if the number of colonies that grow on a drug containing media is 1 % or more of the colonies that grow on a control drug free media. The control (drug free) media must show good growth at least 50 to 150 colonies. M. tuberculosis H37Rv strain used as a control strain. Table-IV ) . it acts at lower P H where bacteria could not grow. So far that reason, P H of the drug media must be adjusted at 5.5 11 . It was not suggested to do drug resistance surveillance against PZA but can be performed in small scale for special reason 18 .
Pyrazinamide (PZA) is a less potent bactericidal drug. It is most important sterilizing drugs because of their ability to kill semi-dormant bacilli capable of surviving bactericidal action of INH and so of giving rise to relapse after treatment. The bacilli specifically killed by PZA are probably those with their metabolism inhibited by an acid environment such as in macrophages and in areas of acute inflammation 16 .
In this study drug resistance of M. tuberculosis to single drug was found in 22.11 % cases, to two drugs in 15.79 %, to three drugs in 10.53 % and to four drugs in 4.21 % cases. One strain was resistant to all the five drugs. In Bangladesh, Van Deun et al found 21. 95% strains were resistant to one drug, 13% resistant to two drugs, 10.5% to three drugs and 8.5% to four or more drugs 19 . Resistances against two or three drugs are difficult to treat and often result in treatment failure 20 .
In the present study 22.11 % strains of M. tuberculosis were Multi-drug resistance tuberculosis (MDR-TB). MDR-TB is usually a death sentence in developing countries as it is an incurable disease for anyone who does not get access to the most sophisticated and expensive health care. Similar rate of multi-drug resistance also reported from Argentina (22.2%), Dominican Republic (19.7%), Spain (20.5%), higher than these rate were found 54.4% in Latvia 21 . Similar rate of MDR-TB was reported from India 25.25% 12 . From Thailand, Riantawan et al reported 25.2% MDR among acquired drug resistance cases 10 . Lower rate 5.56% was reported by Van Duen et al and 6.8% by ICDDR'B from Bangladesh 19. 8 .
The regimen for treatment of tuberculosis has changed very little during last decades; combination drug therapy is the main stream of treatment. Afford have been limited only to changing this combination. Since the methodology of drug susceptibility for Mycobacteria is cumbersome, tedious and takes weeks to come to a conclusion.
So almost similar regimen is prescribed for every tuberculosis patient irrespective of extent of the lesion or the sensitivity pattern of causative strains. Until new drugs are available for treatment of tuberculosis, present regimen will be rendered ineffective by development of resistance, so combination therapy is inevitable for days to come till new more efficient drugs are available in future.
An easy, fast and efficient method for drug susceptibility to M. tuberculosis may change the situation. The proportion method is widely used throughout the world for it is inexpensive, comparison to radiometric method and other molecular methods. Apart from cost the wide spectrum use of 25.2% cases 10 9 . Effective tuberculosis control and management program in developed country like USA, UK, France has a favourable effect on the low incidence of drug resistance, while our tuberculosis control and management program are as effective as our neighbour country and thereby the resistance pattern remain similar in these countries.
In this study highest drug (40.00 %) resistance was found against INH either alone or in combination with other drugs. INH resistance is important, because it is a potent bactericidal drug, and is an important component of short course antituberculosis regimen. It alone may kill 90% of the bacillary population in a patient's lesions during the first few days of chemotherapy 16 . So, resistance against INH may leads to treatment failure. This high rate of INH resistance might be due to wide use of this drug in first line treatment of patients and irregular and inadequate treatment.
Rifampicin was found resistant 32.63 % cases in this study. Rifampicin -the most important drug in DOTS program -is also gradually becoming ineffective due to development of resistance. As Rifampicin is a potent bactericidal and sterilizing drug which act on dormant and persister bacilli on short exposure and resistance to Rifampicin may lead to the failure of DOTS program 17 . The reason for high resistance to Rifampicin might be due to irregular use due to its high cost, using Rifampicin in other condition like Leprosy, Leishmaniasis and PUO. National tuberculosis programme and patient compliance may also have some role.
Drug resistance against Streptomycin (SM) was found 13.68 % in this study. SM is less potent bactcricidal drug and introduced first for the treatment of tuberculosis.
The relatively less SM resistance than INH and RMP might be due to decrease use of it. It is no longer used in standard regimen but in retreatment cases. Out of 95 isolated strains , 11 (11.58 %) were resistant to EMB. It is bacteriostatic drug but in large dose can act as bactericidal 16 . Resistance to PZA was found in 10.53 % cases in our study. PZA susceptibility test is difficult to perform as 
Conclusion
The present study creates the impression that fairly high rate of anti-tuberculosis drug resistance among the tuberculosis patients and also high MDR-TB. By taking history of previous treatment for tuberculosis, drug resistance patients group and new cases from same family should be identified. Susceptibility test of these groups should be performed with all commonly used first line anti-tuberculosis drugs, and then appropriate drugs should be selected for curative treatment to prevent spread of drug resistant tuberculosis. Our priority is not the management, but the prevention of MDR tuberculosis.
